Trial NCT01198158

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2011-02603
Secondary IDs: CALGB 90802 CALGB-90802 CDR0000684313 NCI-2011-02603 U10CA031946 U10CA180821

Last trial update was posted on 2019-03-06

MeSH Interventions

Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological Bevacizumab Endothelial Growth Factors Everolimus Immunoglobulin G Immunoglobulins

MeSH Conditions

Carcinoma Carcinoma, Renal Cell

Other Conditions

Clear Cell Renal Cell Carcinoma Recurrent Renal Cell Carcinoma Stage III Renal Cell Cancer AJCC v7 Stage IV Renal Cell Cancer AJCC v7

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID